Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3680033013 | Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3680035018 | Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 108422801000001112 | Lamivudine 150 mg and zidovudine 300 mg and nevirapine 200 mg oral tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Is a | Product containing lamivudine and nevirapine and zidovudine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Zidovudine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Lamivudine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Nevirapine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Is a | Product containing zidovudine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Is a | Product containing lamivudine and nevirapine and zidovudine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Lamivudine | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Lamivudine | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 150 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Zidovudine | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Zidovudine | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 300 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Nevirapine | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Nevirapine | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 200 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Zidovudine | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Lamivudine | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Nevirapine | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 3 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Is a | Product containing only lamivudine and nevirapine and zidovudine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Zidovudine | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Lamivudine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Zidovudine | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Lamivudine | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR